Trial Profile
Pharmacokinetic (PK) Study of ASP8825 - Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Haemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Alcoholism; Postherpetic neuralgia; Restless legs syndrome
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 15 Dec 2015 New trial record